News & Updates
Filter by Specialty:
Apixaban outdoes rivaroxaban at preventing VTE, bleeding in adults
Patients with venous thromboembolism (VTE) who are new users of apixaban are less likely to experience recurrent VTE and bleeding than new users of rivaroxaban, a study has shown.
Apixaban outdoes rivaroxaban at preventing VTE, bleeding in adults
17 Dec 2021
No benefit from adding interferon beta-1a to remdesivir in COVID-19
Adding interferon beta-1a to remdesivir did not hasten time to recovery among adults hospitalized with COVID-19, according to results of the phase III ACTT*-3 trial.
No benefit from adding interferon beta-1a to remdesivir in COVID-19
16 Dec 2021
DOACs tied to lower risk of delayed ICH than older blood thinning meds
Patients on older antiplatelet or anticoagulant agents who sustain head trauma may be at an increased risk of delayed post-traumatic intracranial haemorrhage (ICH) than those on direct oral anticoagulants (DOACs), according to a retrospective study presented at RSNA 2021.
DOACs tied to lower risk of delayed ICH than older blood thinning meds
14 Dec 2021
Antidepressant therapy: To continue or not?
In individuals who had been on antidepressant therapy for at least 9 months but felt well enough to consider discontinuing, the risk of relapse of depression was greater among those who stopped vs those who carried on with their current regimen, the ANTLER* trial has shown.